![Isaac Kohlberg](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Isaac Kohlberg
Directeur/Membre du Conseil chez
ACACIA RESEARCH CORPORATION
Fortune : 398 178 $ au 30/06/2026
Profil
Isaac Theodore Kohlberg is currently Independent Director at Acacia Research Corp.
since 2019.
Director at TTFactor Società Benefit Srl.
Director at Eclosion2 & Cie Scpc.
Non-Executive Director at Arix Bioscience since 2021.
Chief Technology Development Officer at Harvard University since 2005.
Sr. Associate Provost & Chief Technology Development Officer at the Office of Technology Development since 2005.
Formerly Chief Executive Officer at Ramot at Tel Aviv University Ltd., Tel Aviv University Economic Corp.
Ltd., Tel-Aviv University from 2001 to 2005, and Yeda Research & Development Co. Ltd. Director at eXIthera Pharmaceuticals, Inc. Director at Clal Biotechnology Industries Ltd. from 2015 to 2020.
Director at Allon Therapeutics, Inc. Non-Executive Director at Arix Bioscience Plc from 2021 to 2024.
Director at Anchiano Therapeutics Ltd. from 2017 to 2021.
Director at Elicio Therapeutics, Inc. from 2014 to 2021.
Professor & Vice Provost at New York University from 1989 to 2000.
Strategic Advisor at Access BridgeGap Ventures.
VP-Industrial Liaison, Head-Science & Technology at New York University Medical Center.
Education includes an MBA from INSEAD in 1981 and a graduate degree from Tel-Aviv University in 1979.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 28/04/2026 | 85 446 ( 0,09 % ) | 398 178 $ | 30/06/2026 |
Postes actifs de Isaac Kohlberg
| Sociétés | Poste | Début |
|---|---|---|
| ACACIA RESEARCH CORPORATION | Directeur/Membre du Conseil | 06/05/2019 |
Eclosion2 & Cie Scpc | Directeur/Membre du Conseil | - |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Directeur Technique/Scientifique/R&D | 01/01/2005 |
Office of Technology Development
 Office of Technology Development Investment ManagersFinance Office of Technology Development invests in companies located in the United States. The firm focuses on health and technology sectors. It participates in early-stage transactions. | Directeur Technique/Scientifique/R&D | 01/01/2005 |
TTFactor Società Benefit Srl
 TTFactor Società Benefit Srl Medical/Nursing ServicesHealth Services Develops oncology research, technology advancement and intellectual property transfer programs | Directeur/Membre du Conseil | - |
Arix Bioscience /Venture Capital/
 Arix Bioscience /Venture Capital/ Investment ManagersFinance Arix Bioscience invests in companies located in the United Kingdom. The firm focuses on the therapeutics sector. It participates in early stage capital requirements. | Directeur/Membre du Conseil | 29/04/2021 |
Anciens postes connus de Isaac Kohlberg
| Sociétés | Poste | Fin |
|---|---|---|
| ARIX BIOSCIENCE PLC | Directeur/Membre du Conseil | 22/01/2024 |
Elicio Therapeutics, Inc. (United States)
 Elicio Therapeutics, Inc. (United States) BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops novel immunotherapies for treatment of cancer and other diseases | Directeur/Membre du Conseil | 01/04/2021 |
| ANCHIANO THERAPEUTICS LTD | Directeur/Membre du Conseil | 01/03/2021 |
| ░░░░ ░░░░░░░░░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░ ░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Isaac Kohlberg
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
88
Relations au 1er degré
20
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 20 |
|---|---|
Ramot at Tel Aviv University Ltd.
 Ramot at Tel Aviv University Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as technology transfer company | Commercial Services |
Tel Aviv University Economic Corp. Ltd. | |
Anchiano Therapeutics Ltd.
 Anchiano Therapeutics Ltd. BiotechnologyHealth Technology Provides biopharmaceutical services | Health Technology |
Elicio Therapeutics, Inc. (United States)
Elicio Therapeutics, Inc. (United States) BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops novel immunotherapies for treatment of cancer and other diseases | Health Technology |
eXIthera Pharmaceuticals, Inc.
 eXIthera Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops and manufactures stroke prevention & antithrombosis drugs | Health Technology |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Clal Biotechnology Industries Ltd.
 Clal Biotechnology Industries Ltd. Financial ConglomeratesFinance Provides investment and support services for life science research companies | Finance |
Allon Therapeutics, Inc.
 Allon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures drugs to protect against neurodegenerative conditions | Health Technology |
New York University
 New York University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
INSEAD
 INSEAD Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tel-Aviv University
 Tel-Aviv University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Acacia Research Corp.
 Acacia Research Corp. Miscellaneous Commercial ServicesCommercial Services Engages in patent licensing, printers manufacturing and oil & natural gas exploration & production business | Commercial Services |
Office of Technology Development
Office of Technology Development Investment ManagersFinance Office of Technology Development invests in companies located in the United States. The firm focuses on health and technology sectors. It participates in early-stage transactions. | Finance |
Yeda Research & Development Co. Ltd.
 Yeda Research & Development Co. Ltd. Investment ManagersFinance Initiates and promotes the transfer to the global marketplace of research findings and innovative technologies developed by Weizmann Institute of Science | Finance |
Access BridgeGap Ventures
 Access BridgeGap Ventures Investment ManagersFinance Access Bridgegap Ventures seeks to bridge the early-stage investment gap in the therapeutics space. The firm leverages their experience in start-up creation, technology commercialization and venture investing to fund young start-ups and create de novo spin-offs around potential high-impact technologies, many of which are still in academic research labs. | Finance |
TTFactor Società Benefit Srl
TTFactor Società Benefit Srl Medical/Nursing ServicesHealth Services Develops oncology research, technology advancement and intellectual property transfer programs | Health Services |
Eclosion2 & Cie Scpc | |
Arix Bioscience Plc
 Arix Bioscience Plc Investment ManagersFinance Operates as a global venture capital firm | Finance |
New York University Medical Center
 New York University Medical Center Other Consumer ServicesConsumer Services Operates as a medical university | Consumer Services |
Arix Bioscience /Venture Capital/
Arix Bioscience /Venture Capital/ Investment ManagersFinance Arix Bioscience invests in companies located in the United Kingdom. The firm focuses on the therapeutics sector. It participates in early stage capital requirements. | Finance |
